These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8184403)

  • 21. Macrophage oxidative modification of low density lipoprotein occurs independently of its binding to the low density lipoprotein receptor.
    Tangirala RK; Mol MJ; Steinberg D
    J Lipid Res; 1996 Apr; 37(4):835-43. PubMed ID: 8732783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide.
    Van Lenten BJ; Fogelman AM; Haberland ME; Edwards PA
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2704-8. PubMed ID: 3517876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II.
    Keidar S; Kaplan M; Shapira C; Brook JG; Aviram M
    Atherosclerosis; 1994 May; 107(1):71-84. PubMed ID: 7945561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3.
    Wintergerst ES; Jelk J; Rahner C; Asmis R
    Eur J Biochem; 2000 Oct; 267(19):6050-9. PubMed ID: 10998066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dietary supplementation of beta-carotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein.
    Levy Y; Kaplan M; Ben-Amotz A; Aviram M
    Isr J Med Sci; 1996 Jun; 32(6):473-8. PubMed ID: 8682654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages.
    Snyder ML; Polacek D; Scanu AM; Fless GM
    J Biol Chem; 1992 Jan; 267(1):339-46. PubMed ID: 1530930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor.
    Parthasarathy S; Printz DJ; Boyd D; Joy L; Steinberg D
    Arteriosclerosis; 1986; 6(5):505-10. PubMed ID: 3767695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.
    Nozaki S; Kashiwagi H; Yamashita S; Nakagawa T; Kostner B; Tomiyama Y; Nakata A; Ishigami M; Miyagawa J; Kameda-Takemura K
    J Clin Invest; 1995 Oct; 96(4):1859-65. PubMed ID: 7560077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptors for modified low-density lipoproteins on human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein.
    Kume N; Arai H; Kawai C; Kita T
    Biochim Biophys Acta; 1991 Jan; 1091(1):63-7. PubMed ID: 1995068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Degree of oxidation of low density lipoprotein affects expression of CD36 and PPARgamma, but not cytokine production, by human monocyte-macrophages.
    Kavanagh IC; Symes CE; Renaudin P; Nova E; Mesa MD; Boukouvalas G; Leake DS; Yaqoob P
    Atherosclerosis; 2003 Jun; 168(2):271-82. PubMed ID: 12801610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of modified LDL by cultured human placental cells.
    Bonet B; Chait A; Gown AM; Knopp RH
    Atherosclerosis; 1995 Jan; 112(2):125-36. PubMed ID: 7772073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages.
    Rumsey SC; Obunike JC; Arad Y; Deckelbaum RJ; Goldberg IJ
    J Clin Invest; 1992 Oct; 90(4):1504-12. PubMed ID: 1401083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation by cultured monocyte-derived macrophages from normal and familial hypercholesterolaemic subjects of modified and unmodified low-density lipoproteins.
    Soutar AK; Knight BL
    Biochem J; 1982 May; 204(2):549-56. PubMed ID: 6180739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes.
    Yang M; Chu EM; Caslake MJ; Edelstein C; Scanu AM; Hill JS
    Biochim Biophys Acta; 2010 Feb; 1801(2):176-82. PubMed ID: 19895904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-affinity uptake and degradation of apolipoprotein E free high-density lipoprotein and low-density lipoprotein in cultured porcine hepatocytes.
    Bachorik PS; Franklin FA; Virgil DG; Kwiterovich PO
    Biochemistry; 1982 Oct; 21(22):5675-84. PubMed ID: 6293555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nobiletin metabolite, 3',4'-dihydroxy-5,6,7,8-tetramethoxyflavone, inhibits LDL oxidation and down-regulates scavenger receptor expression and activity in THP-1 cells.
    Lo YH; Pan MH; Li S; Yen JH; Kou MC; Ho CT; Wu MJ
    Biochim Biophys Acta; 2010 Feb; 1801(2):114-26. PubMed ID: 19833227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-density lipoproteins modified by lipid transfer protein have altered biological activity.
    Chait A; Eisenberg S; Steinmetz A; Albers JJ; Bierman EL
    Biochim Biophys Acta; 1984 Sep; 795(2):314-25. PubMed ID: 6477948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.
    Podrez EA; Febbraio M; Sheibani N; Schmitt D; Silverstein RL; Hajjar DP; Cohen PA; Frazier WA; Hoff HF; Hazen SL
    J Clin Invest; 2000 Apr; 105(8):1095-108. PubMed ID: 10772654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet secretory products enhance LDL receptor activity and inhibit scavenger receptor activity in human monocyte derived macrophages.
    Aviram M
    Metabolism; 1989 May; 38(5):425-30. PubMed ID: 2725280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.